Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2,3,4,5-tetrabromo-6-(2,4-dibromophenoxy)phenol | IC50: 0.007 mM | Glycine max | |
2,3,4,5-tetrabromo-6-(2,4-dibromophenoxy)phenol | IC50: 0.0018 mM | Homo sapiens | |
2,3,4,5-tetrabromo-6-(3,5-dibromo-2-hydroxyphenoxy)phenol | IC50: 0.00079 mM | Homo sapiens | |
2,3,5-tribromo-6-(3,5-dibromo-2-hydroxyphenoxy)phenol | IC50: 0.0022 mM | Homo sapiens | |
2,4-dibromo-6-(2,4-dibromo-6-methoxyphenoxy)phenol | IC50: 0.01 mM | Homo sapiens | |
2,4-Dibromophenol | IC50: 0.034 mM | Homo sapiens | |
2,6-dibromo-4-[1-(3-bromo-4-hydroxyphenyl)-1-methylethyl]phenol | IC50: 0.005 mM | Homo sapiens | |
3,4,6,8-tetrabromooxanthren-1-ol | IC50: 0.0009 mM | Homo sapiens | |
3,4,6-tribromo-2-(2,4-dibromophenoxy)phenol | IC50: 0.009 mM | Glycine max | |
3,4,6-tribromo-2-(2,4-dibromophenoxy)phenol | IC50: 0.005 mM | Homo sapiens | |
3,4-dibromo-2-(5-bromo-2-hydroxyphenoxy)phenol | IC50: 0.011 mM | Homo sapiens | |
3,6,8-tribromooxanthren-1-ol | IC50: 0.0008 mM | Homo sapiens | |
3-[3-bromo-5-(2,6-dibromo-4-{2-[2-(3-bromo-4-hydroxy-phenyl)-ethylcarbamoyl]-2-[(E)-hydroxyimino]-ethyl}-phenoxy)-4-methyl-phenyl]-N-[(E)-2-(3,5-dibromo-4-hydroxy-phenyl)-vinyl]-2-[(E)-hydroxyimino]-propionamide | IC50: 0.059 mM | Glycine max | |
3-[3-bromo-5-(2,6-dibromo-4-{2-[2-(3-bromo-4-hydroxy-phenyl)-ethylcarbamoyl]-2-[(E)-hydroxyimino]-ethyl}-phenoxy)-4-methyl-phenyl]-N-[(E)-2-(3,5-dibromo-4-hydroxy-phenyl)-vinyl]-2-[(E)-hydroxyimino]-propionamide | IC50: 0.059 mM | Homo sapiens | |
4,4'-propane-2,2-diylbis(2,6-dibromophenol) | IC50: 0.004 mM | Homo sapiens | |
4-Bromophenol | IC50: 0.048 mM | Glycine max | |
4-Bromophenol | IC50: 0.055 mM | Homo sapiens | |
bestatin | IC50: 0.027 mM | Glycine max | |
bestatin 7 | IC50: 0.027 mM | Homo sapiens | |
additional information | IC50 above 0.1 mM: compound 1a, compound 1b, compound 1d, compound 1e, compound 1g | Homo sapiens | |
nordihydroguaiaretic acid | IC50: 0.0018 mM | Glycine max | |
nordihydroguaiaretic acid | IC50: 0.00011 mM | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Glycine max | - |
- |
- |
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
reticulocyte | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
linoleic acid + O2 | - |
Homo sapiens | 13-hydroperoxy-(9Z,11E)-linoleic acid | - |
? | |
linoleic acid + O2 | - |
Glycine max | 13-hydroperoxy-(9Z,11E)-linoleic acid | - |
? |
Synonyms | Comment | Organism |
---|---|---|
15-hLO | - |
Homo sapiens |
15-LO | - |
Homo sapiens |
15-LO | - |
Glycine max |
15-sLO | - |
Glycine max |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00011 | - |
IC50: 0.00011 mM | Homo sapiens | nordihydroguaiaretic acid | |
0.00079 | - |
IC50: 0.00079 mM | Homo sapiens | 2,3,4,5-tetrabromo-6-(3,5-dibromo-2-hydroxyphenoxy)phenol | |
0.0008 | - |
IC50: 0.0008 mM | Homo sapiens | 3,6,8-tribromooxanthren-1-ol | |
0.0009 | - |
IC50: 0.0009 mM | Homo sapiens | 3,4,6,8-tetrabromooxanthren-1-ol | |
0.0018 | - |
IC50: 0.0018 mM | Glycine max | nordihydroguaiaretic acid | |
0.0018 | - |
IC50: 0.0018 mM | Homo sapiens | 2,3,4,5-tetrabromo-6-(2,4-dibromophenoxy)phenol | |
0.0022 | - |
IC50: 0.0022 mM | Homo sapiens | 2,3,5-tribromo-6-(3,5-dibromo-2-hydroxyphenoxy)phenol | |
0.004 | - |
IC50: 0.004 mM | Homo sapiens | 4,4'-propane-2,2-diylbis(2,6-dibromophenol) | |
0.005 | - |
IC50: 0.005 mM | Homo sapiens | 3,4,6-tribromo-2-(2,4-dibromophenoxy)phenol | |
0.005 | - |
IC50: 0.005 mM | Homo sapiens | 2,6-dibromo-4-[1-(3-bromo-4-hydroxyphenyl)-1-methylethyl]phenol | |
0.007 | - |
IC50: 0.007 mM | Glycine max | 2,3,4,5-tetrabromo-6-(2,4-dibromophenoxy)phenol | |
0.009 | - |
IC50: 0.009 mM | Glycine max | 3,4,6-tribromo-2-(2,4-dibromophenoxy)phenol | |
0.01 | - |
IC50: 0.01 mM | Homo sapiens | 2,4-dibromo-6-(2,4-dibromo-6-methoxyphenoxy)phenol | |
0.011 | - |
IC50: 0.011 mM | Homo sapiens | 3,4-dibromo-2-(5-bromo-2-hydroxyphenoxy)phenol | |
0.027 | - |
IC50: 0.027 mM | Glycine max | bestatin | |
0.027 | - |
IC50: 0.027 mM | Homo sapiens | bestatin 7 | |
0.034 | - |
IC50: 0.034 mM | Homo sapiens | 2,4-Dibromophenol | |
0.048 | - |
IC50: 0.048 mM | Glycine max | 4-Bromophenol | |
0.055 | - |
IC50: 0.055 mM | Homo sapiens | 4-Bromophenol | |
0.059 | - |
IC50: 0.059 mM | Homo sapiens | 3-[3-bromo-5-(2,6-dibromo-4-{2-[2-(3-bromo-4-hydroxy-phenyl)-ethylcarbamoyl]-2-[(E)-hydroxyimino]-ethyl}-phenoxy)-4-methyl-phenyl]-N-[(E)-2-(3,5-dibromo-4-hydroxy-phenyl)-vinyl]-2-[(E)-hydroxyimino]-propionamide | |
0.059 | - |
IC50: 0.059 mM | Glycine max | 3-[3-bromo-5-(2,6-dibromo-4-{2-[2-(3-bromo-4-hydroxy-phenyl)-ethylcarbamoyl]-2-[(E)-hydroxyimino]-ethyl}-phenoxy)-4-methyl-phenyl]-N-[(E)-2-(3,5-dibromo-4-hydroxy-phenyl)-vinyl]-2-[(E)-hydroxyimino]-propionamide | |
0.1 | - |
IC50 above 0.1 mM: compound 1a, compound 1b, compound 1d, compound 1e, compound 1g | Homo sapiens | additional information |